Actual Medicinal Product (AMP) Olmesartan medoxomil 40mg tablets (MSN Laboratories Europe Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product
- Provenance
-
This recommendation is based on the products Olmetec 40mg tablets (Daiichi Sankyo UK Limited) and olmesartan 40mg tablets (Aurobindo Pharma - Milpharm Ltd.).
- Generic
- Olmesartan
- Formulation
- Olmesartan medoxomil 40mg tablets
-
Olmesartan
-
Olmesartan medoxomil 40mg tablets
-
Olmesartan medoxomil 40mg tablets (MSN Laboratories Europe Ltd)
-
-